Clinical Trial Update: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) [Phase 1]

View source ↗

Summary

Phase 1 study of carfilzomib in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, or prolymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cancer | Phase 1 | Status: COMPLETED